Clinical Trial

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

Name: Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth — clinical trial record (NCT07464886)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NAC+MIND

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary goal is to investigate to what extent changes in glutamate and glutathione modulation and functional integration between brain networks associated with emotion and attention regulation are associated with treatment response in mildly depressed youth.

Trial Details

NCT Number	NCT07464886
Lead Sponsor	University of Cincinnati Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions	Mild Depression
Enrollment	160 participants
Start Date	2026-02-26
Primary Completion	2030-03 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-11